Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Commercial biotechnology: an international analysis

Technical Report ·
OSTI ID:6482352
This report assesses the competitive position of the United States with respect to Japan and four European countries - the Federal Republic of Germany, the United Kingdom, Switzerland, and France - believed to be the major competitors in the commercial development of new biotechnology. Although the United States is currently the world leader in both basic science and commercial development of new biotechnology, continuation of the initial preeminence of American companies in the commercialization of new biotechnology is not assured. Japan and other countries have identified new biotechnology as a promising area for economic growth and have therefore invested quite heavily in R and D in this field. Congressional policy options for improving US competitveness in new biotechnology are identified in this report.
Research Organization:
Office of Technology Assessment (U.S. Congress), Washington, DC
OSTI ID:
6482352
Report Number(s):
OTA-BA-218; ON: TI85902089
Country of Publication:
United States
Language:
English

Similar Records

Eighth international NEA/Seabed Working Group meeting Varese, Italy, May 30-June 3, 1983
Conference · Sat Mar 31 23:00:00 EST 1984 · OSTI ID:6926036

Proceedings of the fifth annual NEA-seabed working group meeting
Conference · Mon Sep 01 00:00:00 EDT 1980 · OSTI ID:6833762

Seventh International NEA/Seabed Working Group Meeting
Conference · Fri Oct 01 00:00:00 EDT 1982 · OSTI ID:6612310